by Daniel Schleidt
editor in the Rhein-Main-Zeitung.F. A. Z. Twitter
as a result, the time-consuming approval procedures, the vaccines will need to go through is accelerated. The Fast-Track process aims to support the development of new drugs and vaccines intended for the treatment or prevention of serious diseases and have the Potential to address a high unmet medical need.
The Status was on the basis of preliminary study data from Germany and the United States issued. We will continue to work closely with the FDA to accelerate the clinical development of a vaccine against the Coronavirus, said Özlem Türeci, Chief Medical Officer of Biontech.Updated Date: 13 July 2020, 13:20